Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

K-ras oncogene activation in lung adenocarcinomas from former smokers. Evidence that K-ras mutations are an early and irreversible event in the development of adenocarcinoma of the lung.

Westra WH, Slebos RJ, Offerhaus GJ, Goodman SN, Evers SG, Kensler TW, Askin FB, Rodenhuis S, Hruban RH.

Cancer. 1993 Jul 15;72(2):432-8.

PMID:
8319174
2.

A rapid and simple procedure for the routine detection of ras point mutations in formalin-fixed, paraffin-embedded tissues.

Slebos RJ, Boerrigter L, Evers SG, Wisman P, Mooi WJ, Rodenhuis S.

Diagn Mol Pathol. 1992 Jun;1(2):136-41.

PMID:
1342959
3.

Allele-specific detection of K-ras oncogene expression in human non-small-cell lung carcinomas.

Slebos RJ, Habets GG, Evers SG, Mooi WJ, Rodenhuis S.

Int J Cancer. 1991 Apr 22;48(1):51-6.

PMID:
1850383
4.

Cellular protoonocogenes are infrequently amplified in untreated non-small cell lung cancer.

Slebos RJ, Evers SG, Wagenaar SS, Rodenhuis S.

Br J Cancer. 1989 Jan;59(1):76-80.

5.

Incidence and possible clinical significance of K-ras oncogene activation in adenocarcinoma of the human lung.

Rodenhuis S, Slebos RJ, Boot AJ, Evers SG, Mooi WJ, Wagenaar SS, van Bodegom PC, Bos JL.

Cancer Res. 1988 Oct 15;48(20):5738-41.

6.

Different int-1 region DNA rearrangements within different zones of a single mouse mammary tumor.

Sluyser M, Moncharmont B, van der Valk MA, de Goeij CC, Evers SG.

Virology. 1988 Mar;163(1):11-8. Erratum in: Virology 1990 Feb;174(2):630.

PMID:
2831652
7.

Mutational activation of the K-ras oncogene. A possible pathogenetic factor in adenocarcinoma of the lung.

Rodenhuis S, van de Wetering ML, Mooi WJ, Evers SG, van Zandwijk N, Bos JL.

N Engl J Med. 1987 Oct 8;317(15):929-35.

PMID:
3041218
8.

Hormonal regulation of mouse mammary tumor growth.

Sluyser M, Moncharmont B, Ramp G, de Goeij CC, Evers SG.

J Steroid Biochem. 1987;27(1-3):209-14.

PMID:
2826887
9.

Chemotherapy and hormonal therapy of mouse mammary tumors.

Sluyser M, Evers SG, de Goeij CC.

J Steroid Biochem. 1985 Dec;23(6B):1163-7.

PMID:
4094430
10.

Effect of monohydroxytamoxifen on mouse mammary tumors.

Sluyser M, Evers SG, de Goeij CC.

Eur J Cancer Clin Oncol. 1981 Sep;17(9):1063-5. No abstract available.

PMID:
7198988
11.
12.

Combined endocrine therapy and chemotherapy of mouse mammary tumors.

Sluyser M, de Goeij CC, Evers SG.

Eur J Cancer. 1981 Feb;17(2):155-9. No abstract available.

PMID:
7262152
13.

Changes in sensitivity to cyclophosphamide of mouse mammary tumors during serial transplantation.

Sluyser M, De Goeij CC, Evers SG.

J Natl Cancer Inst. 1981 Feb;66(2):327-30.

PMID:
6935481
14.

Sex hormone receptors in mammary tumours of GR mice.

Sluyser M, Evers SG, De Goeij CC.

Nature. 1976 Sep 30;263(5576):386-9.

PMID:
987544
15.

Binding of 5S estradiol receptor to poly-deoxynucleotides.

Sluyser M, Evers SG, Nijssen T.

Biochem Biophys Res Commun. 1974 Nov 6;61(1):380-8. No abstract available.

PMID:
4374209

Supplemental Content

Loading ...
Support Center